Under Genome India Initiative, the Department of Biotechology (DBT) plans to scan nearly 20,000 Indian genomes over the next 5 years, in a two-phase exercise, and develop diagnostic tests that can be used to test for cancer.
Phases:
The programme is expected to formally launch in October, with an estimated budget of ₹250-350 crore for the Phase-1.
Phase 1: The first phase involves sequencing the complete genomes of nearly 10,000 Indians from all corners of the country and capture the biological diversity of India.
Phase 2: In the next phase, about 10,000 “diseased individuals” would have their genomes sequenced. This vast data would be compared using machine learning techniques to identify genes that can predict cancer and other diseases that could be influenced by genetic anomalies.
Dear Student,
You have still not entered your mailing address. Please enter the address where all the study materials will be sent to you. (If applicable).
